21shares Announces Distributions on TETH and TSOLNEW YORK, March 27, 2026 (GLOBE NEWSWIRE) -- 21shares, one of the world’s largest issuers of cryptocurrency exchange traded products (ETPs), today announced the following distributions of proceeds from the sale of staking rewards earned by 21shares Ethereum ETF (TETH) and 21shares Solana ETF (TSOL).
FRO – Changes to the Board compositionFrontline plc (“Frontline” or the “Company”) announces that Mr. Richard C. Prince has resigned as Director of the Company. The Board would like to thank Mr. Prince for his considerable contribution to the Company during his directorship.
Zefiro Founder Announces Partial Dismissal of New York Litigation and Comments on Annual Meeting ResultsTORONTO, March 27, 2026 (GLOBE NEWSWIRE) -- Dr. Talal A. Debs, Founder of Zefiro Methane Corp. (Cboe: ZEFI) ("Zefiro" or the “Company”), is pleased to announce that his motion to dismiss of a New York civil case (the “NY Litigation”) brought by David McGrath against Dr. Debs, X Machina Capital Strategies Fund I GP LLC (“XMC”), and X Machina Capital Strategies LP (“XMST”) was granted in part. In a decision delivered March 19, 2026, a New York court dismissed multiple allegations included in the NY Litigation. Dr. Debs is confident he and XMC will prevail with respect to the remaining counts.
Magna Posts 2025 Annual ReportAURORA, Ontario, March 27, 2026 (GLOBE NEWSWIRE) -- Magna International Inc. (TSX: MG; NYSE: MGA) today announced that its 2025 Annual Report, including Management’s Discussion and Analysis and Audited Consolidated Financial Statements, Annual Information Form (AIF) and Form 40-F, are now available on the company’s website, www.magna.com. Magna has also filed these documents with the Canadian Securities Administrators (accessible through its website at www.sedarplus.ca) and the U.S. Securities and Exchange Commission (accessible through its website at www.sec.gov/edgar).
FRO – Filing of Annual ReportFrontline plc (the “Company”) announces the filing of its annual report for the year ended December 31, 2025.
The Most Luxurious Carrom Table Ever Created - Reimagined as a Sculptural Design ObjectThe Brar Carrom Table by 11 Ravens and Rydhima Brar reimagines a centuries-old game as a collectible piece of contemporary design.
Brookfield Real Assets Income Fund Inc. Declares Q2 2026 Distribution ScheduleNEW YORK, March 27, 2026 (GLOBE NEWSWIRE) -- Brookfield Real Assets Income Fund Inc. (
NYSE: RA) (the “Fund”) today announced that its Board of Directors (the “Board”) declared the Fund’s monthly distributions for April, May and June 2026.
Manhattan Bridge Capital, Inc. Reports 2025 ResultsGREAT NECK, N.Y., March 27, 2026 (GLOBE NEWSWIRE) -- Manhattan Bridge Capital, Inc. (Nasdaq: LOAN) (the “Company”) announced today that net income for the year ended December 31, 2025 was approximately $5,111,000, or $0.45 per share (based on approximately 11.4 million weighted-average outstanding common shares), versus approximately $5,591,000, or $0.49 per share (based on approximately 11.4 million weighted-average outstanding common shares) for the year ended December 31, 2024, a decrease of approximately $480,000, or 8.6%. This decrease was primarily due to lower interest income, partially offset by lower interest expense.
Diginex Limited Announces Extraordinary General Meeting to Approve Share Capital Increase and Share ConsolidationLONDON, March 27, 2026 (GLOBE NEWSWIRE) -- Diginex Limited (
NASDAQ: DGNX) (“Diginex” or the “Company”), a leading provider of software that helps businesses and governments manage sustainability, regulatory, and supply chain data, today announced that its Board of Directors has resolved to convene an Extraordinary General Meeting of shareholders (the “EGM") to be held on Monday, April 13, 2026 at 10:00a.m. EST for shareholders of record as of the close of business on March 27, 2026.
NIP Group Inc. Announces Receipt of Nasdaq NoticeABU DHABI, United Arab Emirates, March 27, 2026 (GLOBE NEWSWIRE) -- NIP Group Inc. (“NIPG” or the “Company”) (
NASDAQ: NIPG) today announced that it has received a written notification (the “Deficiency Letter”) from the staff of the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) dated March 24, 2026, indicating that for the last 32 consecutive business days, the closing bid price of the Company’s American depositary shares (the “ADSs”) was below the minimum bid price requirement of US$1.00 per share set forth in Nasdaq Listing Rule 5450(a)(1). The Deficiency Letter has no current effect on the listing or trading of the Company’s ADSs on Nasdaq.
TRG Latin America Acquisitions Corp. Announces Closing of Partial Exercise of IPO Over-Allotment OptionNew York, NY, March 27, 2026 (GLOBE NEWSWIRE) -- TRG Latin America Acquisitions Corp. (the “Company”) (
NASDAQ: TRGSU), announced today that the underwriter of its previously consummated initial public offering has partially exercised its option to purchase an additional 632,000 units at the public offering price of $10.00 per unit, resulting in additional gross proceeds of $6,320,000. The underwriter has a remaining option to purchase up to 2,368,000 additional units.
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Operational HighlightsSAN DIEGO, March 27, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today reported its fourth quarter and full-year 2025 operating and financial results and reviewed recent business highlights.
Aqua Metals to Announce Fourth Quarter and Full-Year 2025 Financial Results and Host Investor Conference Call on March 31, 2026RENO, Nev., March 27, 2026 (GLOBE NEWSWIRE) -- Aqua Metals, Inc. (
NASDAQ: AQMS), a pioneer in battery metals recycling and refining, today announced it will report financial results for the fourth quarter and full-year ended December 31, 2025, and provide a business update on Tuesday, March 31, 2026, and host a conference call that day at 4:30 p.m. ET.
Crescent Biopharma Announces Grants of Inducement AwardsWALTHAM, Mass., March 27, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that the independent Compensation Committee of its Board of Directors approved the grant of options to purchase an aggregate of 35,325 shares of the Company’s ordinary shares to three non-executive employees as equity inducement awards under the Crescent Biopharma, Inc. 2025 Employment Inducement Incentive Award Plan, as amended (the “Inducement Plan”). The options were approved on March 26, 2026 and were material to each employee's acceptance of employment with Crescent, in accordance with Nasdaq Listing Rule 5635(c)(4).
iAnthus Reports Fiscal Fourth Quarter and Full Year 2025 Financial ResultsNEW YORK and TORONTO, March 27, 2026 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCID: ITHUF), which owns, operates, and partners with regulated cannabis operations across the United States, today reported its financial results for the fourth quarter and year ended December 31, 2025. The Company’s Annual Report on Form 10-K (the “Annual Report”), which includes its audited consolidated financial statements for the year ended December 31, 2025 and the related management’s discussion and analysis of financial condition and results of operations, can be accessed on the Securities and Exchange Commission’s (“SEC’s”) website at www.sec.gov, on the System for Electronic Document Analysis and Retrieval's (SEDAR+) website at www.sedarplus.com, and on the Company’s website at www.iAnthus.com. The Company’s financial statements are reported in accordance with U.S. generally accepted accounting principles (“GAAP”). All currency is expressed in U.S. dollars.
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)BRISBANE, Calif., March 27, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on March 23, 2026, the Compensation Committee of the Board of Directors (Compensation Committee) of Vera Therapeutics granted inducement awards consisting of non-qualified stock options to purchase 56,850 shares of Class A common stock and restricted stock units (RSUs) underlying 42,403 shares of Class A common stock to Jane Wright-Mitchell, Vera’s new Chief Legal Officer under the Vera Therapeutics, Inc. 2024 Inducement Plan (Inducement Plan). The Compensation Committee approved the awards as an inducement material to the new employee’s employment in accordance with Nasdaq Listing Rule 5635(c)(4).
NorthStrive Biosciences Signs Licensing Agreement Amendment with MOA Life Plus [KOSDAQ: 142760] for Dual Myostatin Assets Targeting Muscle Preservation in Combination with GLP-1 TreatmentsNEWPORT BEACH, Calif., March 27, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc.’s (
NASDAQ: ELAB) (“PMGC,” “we,” or “our”) wholly owned subsidiary, NorthStrive Biosciences Inc. (“Northstrive Biosciences”), announced today a third amendment (“Amendment”) to its existing License Agreement with MOA Life Plus Co., Ltd., [KOSDAQ: 142760] a Korean biotechnology company (“MOA,” and such existing agreement, as amended, “License Agreement”) Northstrive Biosciences holds for EL-32 and EL-22.
Early Warning News Release of X Machina Capital Strategies (XMC)TORONTO, March 27, 2026 (GLOBE NEWSWIRE) -- X Machina Capital Strategies Fund I LP (“XMC”) announces that as a result of the issuance of common shares (the “Common Shares”) pursuant to a debt settlement by Zefiro Methane Corp. ("Zefiro") on January 27, 2026 (the “Debt Settlement”), the common share securityholding percentage of XMC decreased to 23.1%. Subsequently, the XMC sold 155,500 Common Shares during the period of March 23, 2026 to March 26, 2026 (the “March Sales”), representing 0.17% of Zefiro’s issued and outstanding Common Shares. XMC’s Common Share securityholding percentage has decreased from 27.66% to 22.9% since the filing of his last early warning report.
E-Power Inc. and Raytel Electronics Announce Strategic Alliance to Launch Next-Generation 800G and 1.6T High-Speed Optical Modules for U.S. AI Data CentersDOVER, USA, March 27, 2026 (GLOBE NEWSWIRE) -- E-Power Inc. (“E-Power”, the “Company”, “we” or “our”) (
NASDAQ: EPOW), a leading provider of AI Data Center (AIDC) microgrid solutions and advanced battery materials, today announced a landmark strategic partnership with Raytel Electronics (“Raytel”) to co-launch industry-leading 800G and 1.6T high-speed optical modules specifically designed for the North American AI infrastructure market.
SBA Announces National Small Business Week 2026 Award WinnersAdministrator Loeffler to Recognize Honorees during Ceremony in Washington, D.C. on May 3
Atlanta Braves, Gray Media to Simulcast 25 Regular Season Games on Free, Local Over-the-Air Television Stations Across the SoutheastATLANTA, March 27, 2026 (GLOBE NEWSWIRE) -- The Atlanta Braves and Atlanta-based Gray Media announced today a multi-year agreement to bring 25 regular season Braves games to Gray television stations across Braves Country in a simulcast with BravesVision, the Braves’ new, team-owned television platform.The Braves selected Gray Media’s Raycom Sports to produce the full season of non-national games for BravesVision. As part of this multi-year agreement, Raycom Sports will provide end-to-end live production services for BravesVision. The first BravesVision simulcast on Gray stations will air Friday, March 27 (Opening Day), when the Braves host the Kansas City Royals at 7:15 p.m. ET.
CNL STRATEGIC CAPITAL ANNOUNCES OPERATING RESULTS FOR YEAR-END 2025Orlando, Fla., March 27, 2026 (GLOBE NEWSWIRE) -- CNL Strategic Capital, LLC (CNL Strategic Capital or the Company) seeks to provide current income and long-term appreciation to investors by acquiring controlling equity stakes in combination with loan positions in privately owned middle-market businesses. The Company announced its operating results for the year ended Dec. 31, 2025.
Second Fisher House Under Construction at the Pittsburgh VANew Comfort House will more than double support to Veteran families.
VisionSys AI Inc. Announces Pricing of $3 Million Registered Direct OfferingNEW YORK, March 27, 2026 (GLOBE NEWSWIRE) -- VisionSys AI Inc. (
NASDAQ: VSA) ("VisionSys" or the "Company"), an emerging technology services company specializing in brain-machine interaction businesses leveraging core algorithms and related software and hardware systems, today announced that it has entered into securities purchase agreements with certain institutional investors for the purchase and sale of 3,000,000 American Depositary Shares (“ADS”) (or pre-funded warrants in lieu of ADS), at an offering price of $1.00 per ADS.
VEON Reinforces Alignment with Shareholder Value CreationDubai and New York, March 27, 2026 — VEON Ltd. (Nasdaq: VEON; “VEON” or the “Company”), a global digital operator, today provided an update underscoring the strong alignment between its management and shareholders, reflected in meaningful share ownership and disciplined capital allocation.
Transaction in Own SharesTransaction in Own Shares
SBA Announces Grocery Guarantee to Promote Affordability90% Loan Guarantee Drives Capital to U.S. Food and Logistics Providers, Reduces Biden-era Price Pressures
Lowey Dannenberg Notifies Driven Brands Holdings Inc. (“Driven Brands” or the “Company”) (NASDAQ: DRVN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the FirmNEW YORK, March 27, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Driven Brands Holdings Inc. (“Driven Brands” or the “Company”) (
NASDAQ: DRVN) for violations of the federal securities laws on behalf of investors who purchased or acquired Driven Brands securities between May 9, 2023, and February 24, 2026, inclusive (the “Class Period”).
Lowey Dannenberg Notifies Navan, Inc. (“Navan” or the “Company”) (NASDAQ: NAVN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the FirmNEW YORK, March 27, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Navan, Inc. (“Navan” or the “Company”) (
NASDAQ: NAVN) for violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Navan common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s October 2025 initial public offering (“IPO” or the “Offering”).
Lowey Dannenberg Notifies Paysafe Limited (“Paysafe” or the “Company”) (NYSE: PSFE) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the FirmNEW YORK, March 27, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Paysafe Limited (“Paysafe” or the “Company”) (
NYSE: PSFE) for violations of the federal securities laws on behalf of investors who purchased or acquired Paysafe securities between March 4, 2025 and November 12, 2025, inclusive (the “Class Period”).
Monopar Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business UpdateWILMETTE, Ill., March 27, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar,” the “Company,” “we”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announced the fourth quarter and full-year 2025 financial results and provided a summary of recent developments.
A New Kind of Museum: Champions Point to Bring Inspiration, Reflection and Community Impact to Highland ParkHIGHLAND PARK, Ill., March 27, 2026 (GLOBE NEWSWIRE) -- Visionary entrepreneur John Cooper will unveil updated plans for Champions Point, a first-of-its-kind museum experience dedicated to inspiring visitors to recognize their untapped potential and pursue lives of purpose, achievement, and impact, during a Highland Park City Council meeting being held on Monday, March 30th.
MoneyFlare Unveils Next-Generation AI Trading Bot to Power the Future of No-Code Crypto TradingThe 2026 rollout brings real-time AI execution and simplified onboarding to a rapidly growing market.
Colorectal Cancer Advocates Urge Congress to Fund New ResearchWith Young Lives at Stake, More Than 250 Colorectal Cancer Advocates Demand Action
Allot Files Annual Report on Form 20-F for the Year Ended December 31, 2025Hod Hasharon, Israel, March 27, 2026 (GLOBE NEWSWIRE) -- Allot (
NASDAQ: ALLT) (TASE: ALLT), a leading global provider of innovative Security-as-a-Service (SECaaS) and Deep Network Intelligence solutions for communication service providers and enterprises, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission ("SEC").
Beacon Hill Appoints Amy Hess as Director of Associates in DenverDenver, CO, March 27, 2026 (GLOBE NEWSWIRE) -- Beacon Hill announced the appointment of Amy Hess as Director of Beacon Hill Associates in Denver, Colorado, expanding the firm’s administrative and office support staffing presence in the region.
Xtra Edge Launches as a Lightweight Action Camera with 4K, Stabilization, and Sub-$200 Spring PricingXtra has introduced the Xtra Edge, a lightweight action camera that combines 4K capture, Hyper stabilization, waterproof performance, and sub-$200 spring pricing for travel, cycling, and everyday adventure
Palvella Therapeutics Highlights Continued Progress Across Rare Skin Disease Pipeline with Two Poster Presentations at the 2026 American Academy of Dermatology Annual MeetingPoster #76954 highlights QTORIN™ rapamycin’s single phase anhydrous gel formulation designed to optimize dermal bioavailability of rapamycin for mTOR-driven skin diseases while overcoming the crystallization, stability, and dermal penetration challenges posed by rapamycin
Dangbei Spring Promotion with Savings Up to 47% on Popular Home Cinema ProjectorsRefresh home entertainment this Spring by taking advantage of huge savings on top Dangbei projectors on Amazon US
Xtra Atto Gains Attention as a Wearable 4K POV Camera Priced at $299The wearable mini camera combines extended battery life, advanced imaging, and sub-$300 pricing for a new generation of creators
First therapy funded by California taxpayer dollars is approved to treat rare childhood disorderSouth San Francisco, Calif., March 27, 2026 (GLOBE NEWSWIRE) -- The California Institute for Regenerative Medicine (CIRM) celebrates a major milestone in the agency's 21-year history: the first approved therapy to come out of California taxpayer funding. The U.S. Food and Drug Administration (FDA) has given accelerated approval to KRESLADI™, a one-time therapy developed by Rocket Pharmaceuticals, Inc. to treat severe leukocyte adhesion deficiency-I (LAD-I) in children who have no bone marrow donor match for stem cell transplantation.
Leading Edge Materials Annual General Meeting of Shareholders to be Held on April 23, 2026LEADING EDGE MATERIALS ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON APRIL 23, 2026
NASDAQ: ODD INVESTOR ALERT: Berger Montague Advises ODDITY Tech Ltd. (NASDAQ: ODD) Investors of a May 11, 2026 DeadlinePHILADELPHIA, March 27, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces a class action lawsuit against ODDITY Tech Ltd. (
NASDAQ: ODD) (“Oddity Tech” or the “Company”) on behalf of investors who purchased or acquired Oddity Tech shares during the period from February 26, 2025 through February 24, 2026 (the “Class Period”).
Maris-Tech Receives Order to Conduct Situational Awareness Pilot on Armored Vehicle in the United StatesPilot program to demonstrate integrated multi-sensor battlefield awareness capabilities for armored platform crews
Silynxcom Receives a $1.1 Million Purchase Order for Tactical Systems from a Middle East Military ForceNetanya, Israel, March 27, 2026 (GLOBE NEWSWIRE) -- Silynxcom Ltd. (NYSE American: SYNX) (“Silynxcom” or the “Company”), a manufacturer and developer of ruggedized tactical communication headset devices today announced that it has received a purchase order exceeding $1.1 million from a military force in the Middle East for the Company’s Tactical Systems.
Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business UpdateSAN DIEGO, March 27, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB) today announced that its Board of Directors has authorized a Stock Repurchase Plan under which the company may repurchase up to $100,000,000 of the company’s outstanding common stock, par value $0.001 per share, and provided a business update.
Avocado Green Mattress Gains Early 2026 Industry RecognitionLos Angeles, CA, March 27, 2026 (GLOBE NEWSWIRE) -- Avocado Green Mattress, the leader in certified organic and nontoxic sleep products, is already gaining significant recognition in 2026, earning top honors across several major award programs in the first months of the year. Highlights include wins from Good Housekeeping’s 2026 Bedding Awards, Shop TODAY 2026 Sleep Awards, theSkimm Sleep Awards 2026, Forbes Vetted Best Product Awards, and Wirecutter’s Best Latex Mattresses of 2026.
Navigator Medicines Advances NAV-240 into Phase 2a and NAV-242 into the Clinic, Supported by New Positive Data Presented at American Academy of Dermatology (AAD) Annual Meeting 2026SAN MATEO, Calif., March 27, 2026 (GLOBE NEWSWIRE) -- Navigator Medicines Inc., a clinical-stage biotech company pioneering best-in-class bispecific antibodies (bsAb) for inflammatory disorders and autoimmune diseases in areas of high unmet need, today announced it has initiated patient dosing in its Phase 2a MAINSAIL clinical trial evaluating NAV-240, for the treatment of HS. The company has also entered Phase 1 clinical development for its next generation HLE bsAb, NAV-242. This important progress follows positive results across the program presented at the American Academy of Dermatology Congress 2026 in Denver, Colorado, U.S.A.
First Tracks Biotherapeutics, the Planned Spin-Off of Anaptys, Secures Commitments of $145 Million in Private PlacementSAN DIEGO, March 27, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB) today announced that its planned spin-off, First Tracks Biotherapeutics, Inc. (“First Tracks Bio”), and EcoR1 Capital (the “Selling Stockholder”) have entered into a purchase agreement with certain third-party investors for a $145 million private placement, before deducting placement agent fees and other expenses.
Earth Month 2026: 42% of travelers say they take steps to travel more responsibly, according to HolaflyDUBLIN, March 27, 2026 (GLOBE NEWSWIRE) -- Holafly, the leading eSIM provider, reveals new insights into how sustainability is shaping travel decisions worldwide. According to data from the Holafly eSIM & Travel Report, 42% of travelers say they actively take steps to travel more responsibly, highlighting a growing awareness of environmental impact among global explorers.
Jeffs' Brands: KeepZone AI Enters into Agent Agreement with Skyline Software Systems to Offer 3D Geospatial Visualization Solutions to Global Security MarketsTel Aviv, Israel, March 27, 2026 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace expanding into the global homeland security sector through advanced artificial intelligence (“AI”) – driven solutions, today announced that its wholly-owned subsidiary, KeepZone AI Inc. (“KeepZone”), has entered into a non-exclusive Agent Agreement (the “Agreement”) with Skyline Software Systems, Inc. (“Skyline”), a leading provider of 3D geospatial visualization software and services.
